Participants took once-daily oral doses of aleniglipron, with doses increasing every four weeks, or received a placebo over 36 weeks
Monitoring the Full Health Picture The growing popularity of GLP-1 drugs has transformed obesity treatment, but clinicians emphasize that weight loss alone should not be the only measure of success
elevated levels may affect your starting dose or the need for closer monitoring
Why the Letter of Medical Necessity Matters A LOMN can be the deciding factor in whether a patient gets the care they need
The dietary restriction of AGE, in fact, is associated with a significant reduction in inflammatory markers, such as plasma CRP, TNF- (tumor necrosis factor-) and VCAM-1 (vascular cell adhesion molecule-1) [59]
According to Medd, When used alongside retinoids, it can help mitigate potential dryness and irritation while boosting the overall anti-ageing benefits